Analyst Ratings February 6, 2026

Benchmark lifts LiveRamp price target to $40, keeps Buy rating after solid Q3 results

Analyst revisions and near-term execution underpin bullish view despite recent aftermarket weakness

By Caleb Monroe RAMP
Benchmark lifts LiveRamp price target to $40, keeps Buy rating after solid Q3 results
RAMP

Benchmark increased its price target for LiveRamp Holdings Inc. (NYSE: RAMP) to $40 from $38 and maintained a Buy rating, citing steady bookings, operating leverage, and ongoing share repurchases. The firm now expects LiveRamp to exceed 10% revenue growth in fiscal 2027 and raised estimates, while other analysts likewise reaffirmed positive stances after the company reported a stronger-than-expected fiscal third quarter.

Key Points

  • Benchmark raised its price target on LiveRamp to $40 from $38 and kept a Buy rating, citing steady bookings and a healthy outlook.
  • LiveRamp's fiscal Q3 results beat estimates on EPS ($0.76 vs $0.68) and slightly on revenue ($212M vs $211.55M), with revenue up about 9% year over year.
  • Other analysts, including Evercore ISI and Susquehanna, maintained favorable ratings and price targets, highlighting operating income and execution as positive takeaways.

Benchmark on Friday raised its target price for LiveRamp Holdings Inc. (NYSE: RAMP) to $40.00 from $38.00 and left its rating on the stock at Buy. The updated target implies notable upside from LiveRamp's recent share price of $23.06, with InvestingPro data showing the shares trade well below their Fair Value.

The firm pointed to LiveRamp's steady bookings and a healthy outlook as central to the decision to increase the target. Benchmark also highlighted consistent operating leverage and continued share buyback activity as contributors to its more favorable stance.

Benchmark said it is growing more confident that LiveRamp will achieve revenue growth in excess of 10% in fiscal year 2027, noting there are three primary drivers that underpin that expectation. The research house adjusted its estimates upward, a change that directly led to the price target move from $38 to $40 while the Buy recommendation was reaffirmed.

LiveRamp's latest quarterly results helped support the analyst optimism. For the third quarter of fiscal 2026, the company reported earnings per share of $0.76, ahead of the consensus estimate of $0.68 and representing an EPS surprise of 11.76%. Revenue was reported at $212 million against an expectation of $211.55 million, reflecting roughly 9% year-over-year growth.

Other brokerages maintained constructive positions as well. Evercore ISI reiterated an Outperform rating and kept a $37.00 price target, citing operating income that exceeded the firm's guidance. Susquehanna kept a Positive rating with a $50.00 price target, pointing to strong execution and continued sales momentum during the quarter.

Those analyst actions underscore confidence in LiveRamp's recent performance, even as the stock experienced declines during aftermarket trading. Observers have emphasized the company's ability to slightly outpace revenue expectations while delivering a materially larger EPS beat for the quarter.


Analysis and context

Benchmark's upgrade of the price target reflects a combination of upward estimate revisions and qualitative factors the firm highlighted, including a reinforcing mix of operating leverage and shareholder-return activity. The expectation of more than 10% revenue growth in fiscal 2027 is now a central plank of Benchmark's bullish view, supported internally by three identified growth drivers.

Meanwhile, peer analyst notes from Evercore ISI and Susquehanna affirm that the quarter's results met or exceeded key internal metrics such as operating income and execution on sales, contributing to an overall market narrative of improved operational performance for the period.


What this means for investors

  • Benchmark's revised target increases the perceived upside relative to the current share price, reinforcing a Buy stance.
  • Quarterly results showed an EPS beat and modest revenue outperformance, which multiple brokerages cited when maintaining or reiterating positive ratings.
  • Despite analyst support, shares moved lower in aftermarket trading, indicating some market hesitation even as fundamentals reported for the quarter were solid.

Investors should weigh the combination of analyst optimism, improved quarterly metrics, and current market pricing when assessing the stock.

Risks

  • Market reaction: the stock declined in aftermarket trading despite beating quarterly expectations, indicating investor sensitivity to near-term sentiment and valuation.
  • Execution risk: Benchmark's confidence in exceeding 10% revenue growth in fiscal 2027 depends on three drivers noted by the firm; failure of those drivers to materialize would challenge the updated target.
  • Valuation gap: with the stock trading well below its Fair Value per InvestingPro data, there is uncertainty around the timeline and pathway for the market to close that gap.

More from Analyst Ratings

Stifel Lowers JFrog Target Citing AI-Driven Security Concerns; Maintains Buy Rating Feb 22, 2026 HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026